insights_auto
Why is 9926 down 2.29%?
Dive Deeperchevron_right
9926:HKG
Akeso Inc
HK$106.60
arrow_downward
-2.29%(-2.50) 1D
Oct 8, 11:59:50 AM GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 9926...
Open
HK$110.90
High
HK$111.50
Low
HK$106.20
Mkt. cap
94.11B
Avg. vol.
11.84M
Volume
6.59M
52-wk high
HK$156.00
52-wk low
HK$80.20
EPS
-HK$1.24
No. of employees
4K
Open
HK$110.90
High
HK$111.50
Low
HK$106.20
Mkt. cap
94.11B
Avg. vol.
11.84M
Volume
6.59M
52-wk high
HK$156.00
52-wk low
HK$80.20
EPS
-HK$1.24
No. of employees
4K
News stories
From web sources and news partners
Simply Wall Street
·
6 minutes ago
Baidu (BIDU) Faces A Class Action, Is The Upside Still Credible?
The Globe and Mail
·
25 minutes ago
U.S. Analyst Updates: October 7th, 2026
Chosunbiz
·
48 minutes ago
Enchem delays TGHL merger to December amid Nasdaq and SEC reviews - CHOSUNBIZ
Investor's Business Daily
·
2 hours ago
Futures: Memory Giant's Earnings Surge, But Miss Views
Profile
Akeso, Inc is a publicly listed Chinese biopharmaceutical company that is headquartered in Zhongshan, Guangdong.
It is best known for developing Ivonescimab, a cancer treatment antibody. Wikipedia
About Akeso Inc
CEOMichelle Xia | Michelle Xia
Employees4.08K
FoundedMar 19, 2012
Headquarters-
SectorBiotechnology
Websiteakesobio.com